OxyContin ®, like morphine, has a high potential for abuse.
FDA has strengthened the warnings and precautions sections in the labeling of OxyContin ® (oxycodone HCl controlled-release) Tablets, a narcotic drug approved for the treatment of moderate to severe pain. In recent months, there have been numerous reports of OxyContin ® diversion and abuse in several states. Some of these reported cases have been associated with serious consequences including death. In an effort to educate health care providers about these risks, Purdue Pharmaceuticals, manufacturer of the product, has issued a warning in the form of a
 

<< Rapid Opiate Detox

Treatment Alternatives

Get The Help You Deserve

 

MORE ABOUT MRODS

With AAROD the hospital stay is much shorter than traditional opiate detoxification, which can last several days. Other dependency producing drugs such as methadone are not used to replace the opiates and accomplish withdrawal. The patient is able to immediately enter continuing care, and return to work, family, and normal activities much sooner than traditional detoxification methods.

Under the monitored care of a licensed Anesthesiologists (MD), the patient is put under deep sedation for four to six hours with general anesthesia. Administration of the opiate antagonist and a pharmaceutical formula of several medications then flush out the existing active opiates from the patient's opiate receptor sites. Vital signs are monitored at all times, checking for blood pressure, temperature, heart rate, oxygen intake and medicinal delivery.

The actual detoxification process requires a licensed Anesthesiologist (MD) and two nurses who are specifically trained in the AAROD procedure and who will be present at bedside throughout the entire process.

During this rapid detoxification, the patient is completely asleep, experiencing the procedure without enduring physiological discomfort or withdrawal symptoms. The patient emerges from sedation after complete, accelerated physical detoxification is attained. The patient is then carefully monitored in an in-patient setting and is typically released within 24-48 hours of admittance, after a medical examination and a continuing care program has been arranged.

Discharge and Continuing Care

The patient is discharged the following morning after the AAROD procedure and ongoing recovery commenses. MRODS recognizes that detoxification is only the first step in recovery from opiate dependency. Upon completion of the AAROD phase of treatment and discharge from hospitalization, the patient begins a continuing care program to assure continuing recovery.

Depending on the patients individual needs this may include the following:

  • Out-patient treatment
  • Follow-up with a pain specialists
  • Residential treatment
  • Individual counseling

MRODS has a local and national network of approved providers which meets the most stringent criteria for excellence in addiction and pain medicine. MRODS provides follow-up and support for one year after discharge. The patient also begins a six-month regimen with an FDA approved non addicting relapse prevention drug (naltrexone) taken daily.

© 2002 Midwest Rapid Opiate Detoxification Specialists, LLC
Information provided here is for informational purposes only and should not be interpreted as healthcare advice. Always consult with a medical or healthcare professional regarding diagnosis, prognosis, and possible treatment outcomes.